Insulin Glulisine (Vials) and Loteprednol and Tobramycin
Determining the interaction of Insulin Glulisine (Vials) and Loteprednol and Tobramycin and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glulisine
Brand name: Apidra, Apidra OptiClik Cartridge, Apidra SoloStar Pen
Synonyms: Insulin glulisine, Insulin Glulisine
Generic Name: loteprednol / tobramycin ophthalmic
Brand name: Zylet
Synonyms: Loteprednol and tobramycin (ophthalmic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin Glulisine (Vials)-Loteprednol and tobramycin ophthalmic
- Insulin Glulisine (Vials)-Loteprednol Etabonate
- Insulin Glulisine (Vials)-Loteprednol Eye Drops
- Insulin Glulisine (Vials)-Loteprednol Eye Drops 0.2%
- Insulin Glulisine (Vials)-Loteprednol Eye Drops 0.5% and 1%
- Insulin Glulisine (Vials)-Loteprednol Eye Gel
- Loteprednol and Tobramycin-Insulin glulisine Subcutaneous
- Loteprednol and Tobramycin-Insulin human inhaled Inhalation
- Loteprednol and Tobramycin-Insulin human regular Injection
- Loteprednol and Tobramycin-Insulin inhalation
- Loteprednol and Tobramycin-Insulin isophane
- Loteprednol and Tobramycin-Insulin isophane and insulin regular